» Articles » PMID: 32180479

Osteoporosis in Cirrhotics Before and After Liver Transplantation: Relation with Malnutrition and Inflammatory Status

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2020 Mar 18
PMID 32180479
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cirrhosis is associated with osteoporosis and liver transplantation (LT) with increased bone loss. This study aimed to in LT candidates investigate the potential relation between bone mineral density (BMD) and BMD loss in those who undergo LT, with malnutrition, systemic inflammation, and hormonal status. We included 102 consecutively recruited cirrhotic LT candidates between May 2004 and April 2007. BMD was assessed by means of dual energy X-ray absorptiometry (DXA). Malnutrition was defined by means of anthropometry and assessment of recent weight loss. In 75/102 patients, serum-thyroid stimulating hormone (TSH), free triiodthyronine (T3) and free thyroxine (T4) and growth hormone (GH), cortisol, free testosterone, dehydroepiandrosterone sulfate, estradiol, interleukin-6, and tumor necrosis factor (TNF)-α was assessed. Overall 57/102 patients received a LT and 47/102 were followed for one year post-LT. At follow-up, nutritional status and BMD were assessed in all patients ( = 47) while 34/47 had available blood samples for analysis. Forty (40%) LT- candidates had osteopenia or osteoporosis and 34 (38%) were malnourished. Malnutrition was associated with osteopenia/osteoporosis (odds ratio: 3.5, 95% CI 1.4, 9.9). Hip BMD Z-score decreased -0.25 (95% CI -0.41, -0.09) from baseline to one year post-LT. High baseline TNF-α correlated with a more marked decline in BMD (Partial correlation () = -0.47,  < .05) as did high baseline cortisol levels ( = -0.49,  < .05). Malnutrition in liver cirrhosis seems to be associated with osteopenia/osteoporosis, and systemic inflammation (higher TNF-α) and systemic stress (higher cortisol) to bone loss in patients who undergo LT.

Citing Articles

Low geriatric nutritional risk index is associated with osteoporosis and fracture risk in patients with chronic liver disease: a cross-sectional study.

Kamioka H, Saeki C, Oikawa T, Kinoshita A, Kanai T, Ueda K BMC Gastroenterol. 2024; 24(1):376.

PMID: 39448932 PMC: 11515523. DOI: 10.1186/s12876-024-03465-8.


High bone fracture risk in a large modern cohort of liver transplant recipients.

Zavatta G, Vitale G, Morelli M, Pianta P, Turco L, Cappa F Intern Emerg Med. 2024; 20(1):139-150.

PMID: 39331313 PMC: 11794375. DOI: 10.1007/s11739-024-03767-5.


Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX as a Screening Tool.

Sanchez-Delgado J, Profitos J, Arevalo M, Lira A, Marmol C, Miquel M J Clin Med. 2024; 13(1).

PMID: 38202195 PMC: 10780144. DOI: 10.3390/jcm13010188.


Risk factors for fractures following liver transplantation: a population-based cohort study.

Chang J, Yang H, Lin N, Kuo F, Lin T, Tsai H Ann Med. 2023; 55(1):2230871.

PMID: 37455447 PMC: 10353320. DOI: 10.1080/07853890.2023.2230871.


Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

Santos L, Lima T, de Carvalho Nunes H, Qi X, Romeiro F Hepatol Int. 2022; 16(6):1458-1467.

PMID: 35767173 DOI: 10.1007/s12072-022-10366-z.